10.12.2012 Views

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Document<br />

Page 309<br />

site 3 on the sodium channel. The first of these are the short anemone polypeptides [19,24] such as ATX<br />

III [38] and PaTX [39], which are neurotoxic to crustacea. The polypeptide ATX III, which consists of<br />

27 residues cross-linked <strong>by</strong> three disulfide bonds, and PaTX, which has 31 residues and four disulfides,<br />

can be aligned such that 16 residues are identical. The three disulfides in ATX III are linked in a<br />

1–5/2–4/3–6 pattern in the same way as in the long polypeptides [65], but the only other similarity at the<br />

level of primary structure is a GCPXG sequence corresponding to residues 28–32 of AP-A. Although<br />

neurotoxic to crustacea, ATX III is inactive as a positive inotrope [28], suggesting that it possesses an<br />

appropriate structural scaffold to interact with site 3 but lacks key side chains required for interaction<br />

with the cardiac channel. Nevertheless, the smaller size of ATX III makes it an attractive candidate for<br />

further study, with the aim of engineering into it the ability to bind to the cardiac channel. The welldefined<br />

solution structure for this toxin [65] provides and essential basis for such an effort.<br />

The Anemonia sulcata polypeptides BDS I and II [40], which were claimed to have antihypertensive and<br />

antiviral activity, also bind to site 3 on neuronal sodium channels and have weak negative inotropic<br />

activity [41]. The points of similarity and difference between the solution structures of BDS I [40] and<br />

the long anemone polypeptides have been discussed previously [40,41] and will not be reiterated here;<br />

suffice to say that the overall folds are similar but the Arg14 loop in the long polypeptides is truncated in<br />

BDS I and the molecule lacks several residues that have been shown to be important for activity.<br />

B. Scorpion Toxins<br />

The scorpion α-toxins have been shown to bind to site 3 on the voltage-gated sodium channel<br />

[24,27,42]. These polypeptides contain up to 70 residues crosslinked <strong>by</strong> four disulfide bonds, but show<br />

no sequence similarity to the anemone polypeptides. Possible structural similarities have been discussed<br />

[24], and in a theoretical model of the anemone toxin Bg II, some of the cationic residues were in similar<br />

locations to those in the crystal structure of the scorpion toxin Aah II [26].<br />

It is clear that positively charged residues play an important role in the interactions of sea anemone<br />

toxins and scorpion toxins with site 3 on the sodium channel (as indeed they do with other polypeptide<br />

toxins binding to other ion channels) but this role may be relatively more important for the TTXsensitive<br />

sodium channel in nerve and muscle than for the TTX-insensitive channel of the heart. For<br />

example, Bg II, which is more positively charged than AP-A and AP-B (see above), has a higher affinity<br />

for neuronal sodium channels [26], and replacement of Arg12 and Lys49 in AP-B with uncharged<br />

residues favors its binding to the cardiac channel [53]. Similarly, the scorpion α-toxins bind more tightly<br />

to the neuronal channel than the anemone toxins but, as with the Type 2<br />

http://legacy.netlibrary.com/nlreader/nlReader.dll?bookid=12640&filename=Page_309.html [4/5/2004 5:23:49 PM]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!